Harmony Biosciences Holdings

Healthcare · Biotechnology

39.40$ -1.4% vs. previous close Closing price · As of: Oct 6, 2026

Statements

Balance Sheet

Harmony Biosciences Holdings (HRMY) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,373 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet HRMY
Line item	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	–	–	–	107	163	169	320	427	337	360	391	433	464	505	643	674	715	760	778	811	847	858	928	999	1,056	1,108	1,208	1,272	1,272	1,373
Current Assets	84	–	31	31	91	98	250	263	178	205	241	284	280	323	382	400	418	456	463	451	480	458	522	579	643	691	839	907	779	814
Cash	-84	–	–	24	72	76	222	229	141	160	190	234	224	237	261	244	288	317	325	312	333	317	387	453	489	546	647	753	589	550
Cash & Short-Term Investments	84	–	–	24	72	76	222	229	141	160	190	234	224	254	308	323	344	371	371	353	372	347	410	467	507	565	673	775	641	668
Receivables	–	–	4.3	4.3	11	15	16	22	24	31	33	35	38	50	55	55	53	64	67	74	80	83	82	83	106	93	101	97	108	111
Inventory	–	–	1.1	1.1	1.9	2.1	2.3	3.8	4.4	5.0	4.8	4.4	4.6	4.2	3.9	4.3	4.1	4.9	5.1	5.4	5.9	5.6	6.9	7.2	6.4	6.1	6.9	5.4	5.3	6.4
Property, Plant & Equipment	–	–	1.3	1.3	1.2	1.1	1.0	0.9	0.8	0.9	0.9	0.8	0.7	0.7	0.7	0.6	0.5	0.6	–	–	–	–	–	–	–	–	–	–	–	–
Intangible Assets	–	–	–	72	70	68	67	162	158	153	149	144	179	173	167	161	155	149	143	137	131	125	119	113	107	101	95	89	83	77
Total Liabilities	–	–	–	118	209	218	226	330	229	233	239	247	250	259	300	271	272	275	296	344	332	320	331	340	335	335	373	401	361	374
Current Liabilities	–	–	20	20	16	21	32	135	33	37	48	54	57	66	107	79	85	93	112	164	154	147	161	175	175	180	223	252	217	234
Short-Term Debt	–	–	–	–	–	–	–	–	–	–	2.0	3.4	2.0	2.0	2.0	2.0	6.5	13	17	16	17	17	17	18	19	20	21	87	63	20
Accounts Payable	–	–	6.4	6.4	4.9	2.1	9.3	2.6	4.4	2.0	4.2	1.0	6.9	6.7	10	3.8	6.4	6.6	6.5	18	15	23	11	14	17	28	26	18	29	22
Long-Term Debt	–	–	–	98	192	193	193	194	195	196	190	190	190	190	190	190	185	180	182	179	175	171	168	163	158	153	149	144	139	134
Shareholders' Equity	82	–	–	-12	-46	-49	95	97	108	127	152	187	215	247	344	403	443	485	481	467	515	539	597	659	721	773	835	870	910	999
Retained Earnings	–	–	-423	-423	-472	-483	-488	-488	-481	-467	-476	-454	-432	-409	-321	-272	-243	-208	-170	-143	-105	-93	-47	2.2	48	88	138	161	193	269
Shares Outstanding	55	55	55	55	55	63	60	57	59	59	58	60	61	61	61	62	61	61	61	59	58	58	58	58	59	58	59	59	59	59

Data as of: October 6, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings